New vaccine aims to train immune system to stop throat Cancer's comeback
NCT ID NCT06007092
Summary
This early-stage trial is testing a new therapeutic vaccine designed for people who have been treated for HPV-positive throat cancer and are currently cancer-free. The goal is to see if the vaccine is safe and can teach the body's immune system to recognize and attack any remaining HPV-infected cells, potentially preventing the cancer from coming back. The study will test two different dose levels in a small group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gustave Roussy
RECRUITINGVillejuif, 94 805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.